ISSUE NO. 35 — Critical Considerations for the Safe and Compliant Manufacture of Highly Potent Drugs

Read more about ISSUE NO. 35 — Critical Considerations for the Safe and Compliant Manufacture of Highly Potent Drugs

Getting to the Heart of Science With Marta Rodriguez

Discover the inspiring journey of Altasciences’ Marta Rodriguez, who decided to pursue science after her parents fell ill.

To Marta, science symbolizes the promise of finding cures.

Watch the video

ISSUE NO. 34 — Toxicokinetics, Pharmacokinetics, and Pharmacodynamics

Read more about ISSUE NO. 34 — Toxicokinetics, Pharmacokinetics, and Pharmacodynamics

Choosing the Best Bioanalytical Platform for Your Program

Choosing the right bioanalytical platform for your molecule’s intended use and program segment is crucial to obtaining reliable, robust data in a timely manner.

Comprehensive Solutions for Your First-in-Human Trials

A Partner You Can Trust

Altasciences has decades of experience designing, conducting, and reporting on first-in-human (FIH) clinical trials. Simple or complex, we have the expertise, purpose-built Phase I facilities, and seamless processes to deliver quality with speed and ease. Benefit from our customized approach, including clinical pharmacology units and integrated, state-of-the-art bioanalytical laboratories in the U.S. and Canada, along with the full range of complementary services.

Have a look at these resources to learn more:

The Altascientist:

Maximizing Drug Formulation for First-in-Human Trials

Planning Your First-in-Human Trial

Webinar: A Hop Across the Pond—Discovering the Many Advantages of Conducting Early Phase Clinical Trials in North America

Have questions? Contact our experts today.

Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services.